Jones Keith Anthony bought 30,000 shares of Humacyte, Inc. at $0.59 for $17.8k on Aug 17, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Director
DIR
Filed Aug 19, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$17,820Shares × reported price
Shares traded
30,000Common Stock
Price per share
$0.59Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
30,000Direct
Trade date
Aug 17, 2026Buy
Filed
Aug 19, 2026, 4:00 PM ET2-day reporting delay
Accession
0001193125-26-356847Code P · Transaction 10928
How reported position traded is calculated

New position: there is no prior reported position to use as a percentage baseline.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

HUMA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HUMA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −9.6%1w ago +1.4%1d ago −18%
Returns since7d −6.8%30d −21%90d180d1y

Footnotes in full

F1: The price is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $0.590 to $0.596. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.